Danaher Easily Beats Q2 Street View With Growth From Base Business; FY22 Outlook Unchanged
Danaher Corp (NYSE:DHR) has logged Q2 FY22 adjusted EPS of $2.76, up 12% Y/Y, surpassing the estimate of $2.35. Sales…
Tesla Reveals It Sold 75% Of Bitcoin Holdings: What’s Next For Tesla and Bitcoin?
When Tesla Inc (NASDAQ: TSLA) announced second-quarter earnings after the market close Wednesday, the electric automaker revealed it ha
AbbVie, iSTAR Medical Inks Strategic Alliance For Glaucoma Treatment
AbbVie Inc (NYSE:ABBV) announced a strategic transaction to develop and commercialize iSTAR Medical’s MINIject device, a minimally invasive glaucoma surgical (MIGS)…
Elevance Health Raises Annual Profit Guidance
Elevance Health Inc (NYSE:ELV), previously known as Anthem Inc, has reported Q2 FY22 adjusted EPS of $8.04, up 14.4% Y/Y, beating…
Ernst & Young CEO Expects $10B From Tech Giant Contracts After Historical Business Split: Report
Ernst & Young’s global CEO said that the business split would win its consulting division as much as $10 billion…
Novavax’s COVID-19 Vaccine For Adults Gets CDC Advisory Committee Recommendation
The U.S. Centers for Disease Control and Prevention’s (CDC) advisory committee recommended using Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine as a two-dose…
European Commission Signs COVID-19 Drug Procurement Deal With Gilead
Gilead Sciences Inc (NASDAQ:GILD) and the European Commission signed a joint procurement agreement for rapid and equitable access to the COVID-19…
The Daily Biotech Pulse: FDA Tentatively Approves Avadel’s Narcolepsy Drug, European Approval Broadens AstraZeneca’s Enhertu in Breast Cancer, Pharma Giants’ Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours:
Tesla In Yet Another Legal Soup After German Suit Over Carbon Emission, Data Privacy
Tesla Inc (NASDAQ:TSLA) has landed in another legal soup as Germany’s largest consumer protection group, the Federation of German…